Offered by the Centers for Medicare and Medicaid Services (CMS), the Medicare GLP-1 Bridge will provide coverage of certain GLP-1 medications to eligible Part D participants for a short-term program focused on weight loss
This gap highlights the clinical need for targeted nutritional counseling and, when necessary, supplementation
Recalls & Warnings April 20, 2026 FDA Warns Consumers Not to Use Certain Pain Relief Supplements On April 7, 2026, the FDA warned consumers not to purchase or use eight supplements labeled as containing hyaluronic acid and promoted for pain relief because they contain undeclared drugs
The pill is available in strengths of 1.5 mg, 4 mg, 9 mg, and 25 mg, with a starting dose of 1.5 mg
Your stomach can't tell the difference between medicine and food, so it would normally just break the semaglutide down before it can do anything